2781 - 2790 of 4301 Drugs
Lantus (insulin glargine [rdna origin] injection)
Lantus (insulin glargine [rdna origin]) Injection is a man-made form of a hormone that is produced in the body used to treat type 1 (insulin-dependent) or type 2 (non insulin-dependent) diabetes.
Soliqua Injection (insulin glargine and lixisenatide)
Soliqua 100/33 (insulin glargine and lixisenatide injection) is a combination of a long-acting human insulin analog with a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin (less than 60 units daily) or lixisenatide.
Semglee (insulin glargine injection)
Semglee (insulin glargine injection) is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Toujeo (insulin glargine injection for subcutaneous use)
Toujeo (insulin glargine) Injection is along-acting insulin indicated to improve glycemic control in adults with diabetes mellitus.
Toujeo U 300 (insulin glargine injection for subcutaneous use)
Toujeo U-300 (insulin glargine) is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients 6 years and older with diabetes mellitus.
Rezvoglar (insulin glargine-aglr injection)
Rezvoglar (insulin glargine-aglr) is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Velosulin (insulin human)
Velosulin (insulin human) is a form of insulin used to treat diabetes mellitus. The brand name Velosulin is discontinued, but generic versions may be available.
Novolin N (insulin isophane)
Novolin N (insulin isophane human) is an intermediate-acting human insulin indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
Lyumjev (insulin lispro-aabc injection)
Lyumjev (insulin lispro-aabc) is a rapid-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus.
Myxredlin (insulin regular human)
Myxredlin (insulin human in sodium chloride injection) is a short-acting human insulin indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.